首页 > 市场调查报告书 > 医疗设备

体外诊断

凝血市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按疾病适应症、类型、产品、技术、最终用户和地理位置

市场调查报告书

商品编码

1372558

凝血市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按疾病适应症、类型、产品、技术、最终用户和地理位置

Coagulation Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications, Type, Offering, Technology, End User, and Geography

出版日期: 2023年10月11日 | 出版商:

The Insight Partners | 英文 250 Pages | 订单完成后即时交付

价格

简介目录图表

凝血市场预计将从2022年的62.95亿美元成长到2030年的108.53亿美元；预计2022年至2030年复合年增长率为7.0%。

生活习惯的改变和老年人口的增加是增加血液疾病盛行率的主要因素。因此，早期诊断和治疗的需求日益增长。主要参与者正在透过各种有机和无机策略采取多项倡议，以提高患者群体的生活品质。

2020年7月，希森美康公司在日本推出自动凝血分析仪CN-6500/CN-3500。此分析仪可测量凝血和血小板聚集参数，以及血栓形成和止血参数。

2020年4月，美国Haemonetics公司收购了凝血诊断系统开发商Enicor。

2021 年 10 月，Trivitron Healthcare 推出了由印度 Diagon Ltd 製造的新系列凝血分析仪产品。

2021 年 6 月，Trivitron Healthcare 推出了 NANO H5 和 NANO H110，有助于监测糖尿病、血红素变异和地中海贫血。

2021 年 2 月，西门子医疗与希森美康公司续签了全球供应、分销、销售和服务止血产品的协议。该协议还包括延期多年。此外，西门子 Healthineers 也同意分销 Sysmex 的自动凝血分析仪，例如 CN-3000 和 CN-6000。

2022年7月，HORIBA Medical推出了最新的Yumizen G800和G1550止血分析仪，以及一系列用于常见凝血测试的便捷即用型试剂。随着产品线的扩展，HORIBA Medical 现在为各种规模和要求的实验室提供全面的止血系统和先进试剂选择。

因此，主要市场参与者采用各种有机和无机策略预计将为预测期内混凝市场的成长提供机会。

心血管疾病盛行率上升推动凝血市场的成长

心臟病是心房颤动和中风等疾病导致住院、死亡和身体机能下降的主要原因之一。它影响止血系统、血管系统和血液的流体动力学，并导致动脉和静脉血栓形成。血栓形成是心血管疾病死亡和併发症的主要原因。因吸烟和高血压而受损的血管会在血管内壁形成富含胆固醇的斑块，这些斑块会破裂并导致血小板凝结。凝血障碍有心肌梗塞、中风和血管床动脉粥状硬化血栓事件的风险。心臟衰竭（HF）与血栓栓塞风险增加有关，与心房颤动（AF）的存在无关。血小板活化和凝血系统异常会增加心臟衰竭患者发生严重血栓栓塞事件的风险。

根据 2022 年心臟病和中风统计更新情况说明书，2020 年全球约有 1.191 亿人死于心血管疾病，中风和缺血性中风病例分别约为 8,910 万和 6,820 万例。根据国家慢性病中心预防和健康促进，到2023 年，美国报告每年约有877,500 人死于心臟病。据美国心臟协会称，到2035 年，将有超过1.3 亿美国人可能患有某种形式的心血管疾病。根据“2019 年全球疾病负担研究”，心血管疾病是2019 年亚太地区的主要原因，导致1080 万人死亡。或死亡总数的35%。

凝血测试有助于预防潜在的心臟病发作引起的血液凝固。在冠状动脉绕道手术和血管成形术期间使用凝血分析仪来监测凝血状态的资讯。因此，心血管疾病发生率的上升促进了凝血市场的成长。

凝血市场根据疾病适应症、类型、产品、技术、最终用户和地理位置进行细分。根据疾病适应症，凝血市场分为维生素 K 缺乏症、肝病、瀰漫性血管内凝血及肺栓塞、循环抗凝血剂开发、血友病、冯维勒布兰氏症等。根据类型，凝血市场分为临床实验室分析仪和即时检测分析仪。临床实验室分析仪由对照品及校正品、分析物及试剂、仪器/系统、凝血因子等组成。根据提供的产品，凝血市场分为诊断和治疗。诊断环节又分为凝血酶原时间检测、纤维蛋白原检测、活化凝血时间检测、活化部分凝血活酶时间检测、D-二聚体检测、血小板功能检测等。治疗领域进一步分为抗纤溶药物、避孕药、去氨加压素和免疫抑制药物、维生素K补充剂、血液稀释剂、凝血酶抑制剂或血栓溶解剂、替代疗法、导管辅助血栓清除等。根据技术，凝血市场分为光学技术、机械技术、电化学技术等。根据最终用户，凝血市场分为临床实验室、医院等。

根据地理位置，市场分为北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。北美在凝血市场中占有最大的市场份额。由于血液疾病发病率不断上升、心房颤动 (AFib) 等心血管疾病的发生率不断增加，以及主要市场参与者从事新产品和现有产品开发，北美占据了重要的市场份额。美国在北美凝血市场占有最大份额。血液疾病病例的不断增加、心血管疾病的盛行率不断上升以及政府对预防血液疾病的支持预计将在预测期内推动北美凝血市场的成长。根据加拿大预防保健工作小组的数据，加拿大 AFib 的发生率每年增加 4.5%，40 岁以上人口的终身风险约为 25%。约 30 万加拿大人携带遗传性出血疾病基因。其中十分之一（至少 30,000 名加拿大人）的症状严重到需要医疗照护。其中许多人尚未得到正确诊断。只有 10,000 名遗传性出血性疾病患者在加拿大遗传性出血性疾病综合护理诊所网路中进行了登记。据加拿大血友病协会称，约 30 万加拿大人携带遗传性血液病基因。因此，先天性血液疾病病例数量的增加可能与加拿大凝血市场的成长有关。

美国心臟协会 (AHA)、疾病管制与预防中心 (CDC)、欧盟和加拿大预防保健工作小组是在准备凝血市场报告时提到的几个关键的主要和次要来源。

主要市场驱动因素：
- 市场驱动因素
- 血液疾病盛行率增加
- 心血管疾病盛行率上升
市场限制
- 与凝血分析仪相关的高成本
市场机会
- 主要市场参与者不断发展有机和无机策略
未来的趋势
- 即时护理 (POC) 凝血分析仪的开发
影响分析

第 6 章：凝固市场 - 全球市场分析

凝固市场收入，2022 - 2030
地理分析市场收入，2022 - 2030

第 7 章：全球凝血市场 - 收入和 2030 年预测 - 按疾病适应症

概述
2022 年及 2030 年按疾病适应症分類的凝血市场收入份额 (%)
维生素 K 缺乏
肝病
瀰漫性血管内凝血及肺栓塞
循环抗凝血剂的开发
血友病
血管性血友病
其他的

第 8 章：全球凝固市场 - 收入和 2030 年预测 - 按类型

概述
2022 年和 2030 年按类型分類的凝固市场收入份额 (%)
临床实验室分析仪
即时检测分析仪

第 9 章：全球凝固市场 - 收入和 2030 年预测 - 透过产品

概述
2022 年及 2030 年凝固市场收入份额（按产品划分）
诊断
治疗

第 10 章：全球凝固市场 - 收入和 2030 年预测 - 按技术分类

概述
2022 年和 2030 年按技术分類的凝血市场收入份额 (%)
光学技术
机械技术
电化学技术
其他的

第 11 章：全球凝固市场 - 收入和 2030 年预测 - 按最终用户

概述
2022 年和 2030 年按最终用户分類的混凝市场收入份额 (%)
临床实验室
医院
其他的

第 12 章：凝固市场 - 地理分析

北美洲
- 我们
- 加拿大
- 墨西哥
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 欧洲其他地区
亚太地区
- 太平洋
  - 中国
  - 日本
  - 印度
  - 澳洲
  - 韩国
  - 亚太地区其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区

第 13 章：混凝市场产业格局

概述
凝固市场的成长策略
无机成长策略
- 概述
有机成长策略
- 概述

第 14 章：公司简介

Siemens Healthineers AG
Diagnostica Stago, Inc
ImproGen Diagnostik Kimya San. & Tic. Ltd.?ti.
Nordic Biomarker AB
Sysmex Corp
Helena Laboratories Corporation
F. Hoffmann-La Roche Ltd
Genrui Biotech Co., Ltd.
Transasia Bio-Medicals Ltd
Horiba Ltd.

第 15 章：附录

关于我们
专业术语

简介目录图表

Product Code: TIPRE00030085

The coagulation market is expected to grow from US$ 6.295 billion in 2022 to US$ 10.853 billion by 2030; it is anticipated to record a CAGR of 7.0% from 2022 to 2030.

Changing lifestyle habits and a growing geriatric population are among the major factors increasing the prevalence of blood disorders. Therefore, there is a growing demand for early diagnosis and treatment. Key players are taking several initiatives through various organic and inorganic strategies to enhance the quality of life of patient population.

In July 2020, Sysmex Corporation launched the Automated Blood Coagulation Analyzers CN-6500/CN-3500 in Japan. The analyzer measures blood coagulation and platelet aggregation parameters, as well as thrombosis and hemostasis parameters.

In April 2020, US-based Haemonetics Corporation acquired Enicor, a blood coagulation diagnostic system developer.

In October 2021, Trivitron Healthcare launched a new line of coagulation analyzer products manufactured by Diagon Ltd in India.

In June 2021, Trivitron Healthcare introduced NANO H5 and NANO H110, which help in monitoring diabetes, hemoglobin variations, and thalassemia.

In February 2021, Siemens Healthineers and Sysmex Corporation renewed their agreement to supply, distribute, sell, and service hemostasis products across the world. The agreement also included an extension for multiple years. Further, Siemens Healthineers agreed to distribute Sysmex's automated blood coagulation analyzer, such as the CN-3000 and CN-6000.

In July 2022, HORIBA Medical launched the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a range of convenient ready-to-use reagents for common blood coagulation tests. With this expansion of its product line, HORIBA Medical now offers a comprehensive selection of hemostasis systems and advanced reagents for laboratories of all sizes and requirements.

Thus, the adoption of various organic and inorganic strategies by the key market players is expected to provide opportunities for the coagulation market growth during the forecast period.

Rising Prevalence of Cardiovascular Diseases drives the growth the Coagulation Market

Heart disease is one of the leading causes of hospitalization, death, and reduced physical performance due to conditions such as atrial fibrillation and stroke. It affects the hemostatic system, vascular system, and fluid dynamics of blood and causes arterial and venous thrombosis. Thrombosis is the leading cause of death and complications from cardiovascular disease. Blood vessels damaged by smoking and high blood pressure form cholesterol-rich plaques lining the blood vessels, which can rupture and cause platelets to clot. With coagulation disorders, there is a risk of myocardial infarction, stroke, and atherothrombotic events in the vascular beds. Heart failure (HF) is related to an increased risk of thromboembolism independent of the presence of atrial fibrillation (AF). Platelet activation and coagulation system abnormalities can increase the risk of serious thromboembolic events in patients suffering from HF.

According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet, ~119.1 million deaths due to CVDs and around 89.1 million and 68.2 million stroke and ischemic stroke cases, respectively, are recorded across the world in 2020. Per the National Center for Chronic Disease Prevention and Health Promotion, in 2023, the US reports ~877,500 deaths due to heart diseases every year. According to the American Heart Association, more than 130 million Americans are likely to acquire some form of CVD by 2035. As per 'Global Burden of Disease Study 2019,' CVDs were the leading cause of deaths in Asia Pacific in 2019, causing 10.8 million or 35% of the total fatalities.

A coagulation test helps prevent potential heart attack-causing blood clotting. A coagulation analyzer is used during coronary artery bypass surgery and angioplasty to monitor information on blood clotting status. Thus, the growing incidence of cardiovascular diseases bolsters the coagulation market growth.

The coagulation market is segmented on the basis of disease indication, type, offering, technology, end user, and geography. Based on disease indication, the coagulation market is segmented into vitamin K deficiency, liver disease, disseminated intravascular coagulation & pulmonary embolism, circulating anticoagulant development, hemophilia, von Willebrand's disease, and others. Based on type, the coagulation market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. Clinical laboratory analyzers consist of controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others. Based on offering, the coagulation market is segmented into diagnosis and treatment. The diagnosis segment is further classified into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, D-dimmer testing, platelets function testing, and others. The treatment segment is further classified into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin K supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapies, catheter-assisted thrombus removal, and others. Based on technology, the coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. Based on end user, the coagulation market is segmented into clinical laboratories, hospitals, and others.

Based on geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share of the coagulation market. North America accounts for a significant market share owing to the growing incidences of blood disorders, increasing occurrence of cardiovascular diseases such as atrial fibrillation (AFib), and the presence of major market players engaged in new and existing product developments. The US holds the largest share of the coagulation market in North America. The burgeoning cases of blood disorders, growing prevalence of cardiovascular diseases, and government support for preventing blood disorders are anticipated to boost the North America coagulation market growth during the forecast period. As per the Canadian Task Force on Preventive Health Care, the incidence of AFib in Canada increases by 4.5% per year, with a lifetime risk of ~25% among people aged more than 40 years. Approximately 300,000 Canadians carry an inherited bleeding disorder gene. 1 in 10 of these people-at least 30,000 Canadians-have symptoms severe enough to require medical care. Many of them have not been properly diagnosed. Only 10,000 people with inherited bleeding disorders are registered in the Canadian network of comprehensive care clinics for inherited bleeding disorders. According to the Canadian Hemophilia Society, ~300,000 Canadians carry a gene for an inherited blood disorder. Thus, the rising number of cases of congenital blood disorders can be associated with the growth of the coagulation market in Canada.

American Heart Association (AHA), Centers for Disease Control and Prevention (CDC), European Union, and Canadian Task Force on Preventive Health Care are a few key primary and secondary sources referred to while preparing the report on the coagulation market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the coagulation market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the coagulation market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the coagulation market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Coagulation Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Coagulation Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Market Drivers
- 5.1.2 Increasing Prevalence of Blood Disorders
- 5.1.3 Rising Prevalence of Cardiovascular Diseases
5.2 Market Restraints
- 5.2.1 High Costs Associated with Coagulation Analyzers
5.3 Market Opportunities
- 5.3.1 Growing Organic and Inorganic Strategies by Key Market Players
5.4 Future Trends
- 5.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
5.5 Impact Analysis

6. Coagulation Market - Global Market Analysis

6.1 Coagulation Market Revenue (US$ million), 2022 - 2030
6.2 Geography Analysis Market Revenue (US$ million), 2022 - 2030

7. Global Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

7.1 Overview
7.2 Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
7.3 Vitamin K Deficiency
- 7.3.1 Overview
- 7.3.2 Vitamin K Deficiency: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Liver Disease
- 7.4.1 Overview
- 7.4.2 Liver Disease: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
- 7.5.1 Overview
- 7.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Development of Circulating Anticoagulant
- 7.6.1 Overview
- 7.6.2 Development of Circulating Anticoagulant: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Hemophilia
- 7.7.1 Overview
- 7.7.2 Hemophilia: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Von Willebrand's Disease
- 7.8.1 Overview
- 7.8.2 Von Willebrand's Disease: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.9 Others
- 7.9.1 Overview
- 7.9.2 Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Coagulation Market - Revenue and Forecast to 2030 - by Type

8.1 Overview
8.2 Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
8.3 Clinical Laboratory Analyzers
- 8.3.1 Overview
- 8.3.2 Clinical Laboratory Analyzers: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Global Coagulation Market, by Clinical Laboratory Analyzers
8.4 Point-of-Care Testing Analyzers
- 8.4.1 Overview
- 8.4.2 Point-of-Care Testing Analyzers: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Coagulation Market - Revenue and Forecast to 2030 - by Offering

9.1 Overview
9.2 Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
9.3 Diagnosis
- 9.3.1 Overview
- 9.3.2 Diagnosis: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 9.3.2.1 Global Coagulation Market, by Diagnosis
9.4 Treatment
- 9.4.1 Overview
- 9.4.2 Treatment: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 9.4.2.1 Global Coagulation Market, by Treatment

10. Global Coagulation Market - Revenue and Forecast to 2030 - by Technology

10.1 Overview
10.2 Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
10.3 Optical Technology
- 10.3.1 Overview
- 10.3.2 Optical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Mechanical Technology
- 10.4.1 Overview
- 10.4.2 Mechanical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Electrochemical Technology
- 10.5.1 Overview
- 10.5.2 Electrochemical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. Global Coagulation Market - Revenue and Forecast to 2030 - by End User

11.1 Overview
11.2 Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
11.3 Clinical Laboratories
- 11.3.1 Overview
- 11.3.2 Clinical Laboratories: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
11.4 Hospitals
- 11.4.1 Overview
- 11.4.2 Hospitals: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
11.5 Others
- 11.5.1 Overview
- 11.5.2 Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

12. Coagulation Market - Geographical Analysis

12.1 North America Coagulation Market, Revenue And Forecast To 2030
- 12.1.1 Overview
- 12.1.2 North America Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.1.3 North America Coagulation Market, by Disease Indication
- 12.1.4 North America Coagulation Market, by Type
  - 12.1.4.1 North America Coagulation Market, by Clinical Laboratory Analyzers
- 12.1.5 North America Coagulation Market, by Offering
  - 12.1.5.1 North America Coagulation Market, by Diagnosis
  - 12.1.5.2 North America Coagulation Market, by Treatment
- 12.1.6 North America Coagulation Market, by Technology
- 12.1.7 North America Coagulation Market, by End User
  - 12.1.7.1 North America Coagulation Market, by Country
  - 12.1.7.2 US
    - 12.1.7.2.1 Overview
    - 12.1.7.2.2 US Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.1.7.2.3 US Coagulation Market, by Disease Indication
    - 12.1.7.2.4 US Coagulation Market, by Type
    - 12.1.7.2.4.1 US Coagulation Market, by Clinical Laboratory Analyzers
    - 12.1.7.2.5 US Coagulation Market, by Offering
    - 12.1.7.2.5.1 US Coagulation Market, by Diagnosis
    - 12.1.7.2.5.2 US Coagulation Market, by Treatment
    - 12.1.7.2.6 US Coagulation Market, by Technology
    - 12.1.7.2.7 US Coagulation Market, by End User
  - 12.1.7.3 Canada
    - 12.1.7.3.1 Overview
    - 12.1.7.3.2 Canada Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.1.7.3.3 Canada Coagulation Market, by Disease Indication
    - 12.1.7.3.4 Canada Coagulation Market, by Type
    - 12.1.7.3.4.1 Canada Coagulation Market, by Clinical Laboratory Analyzers
    - 12.1.7.3.5 Canada Coagulation Market, by Offering
    - 12.1.7.3.5.1 Canada Coagulation Market, by Diagnosis
    - 12.1.7.3.5.2 Canada Coagulation Market, by Treatment
    - 12.1.7.3.6 Canada Coagulation Market, by Technology
    - 12.1.7.3.7 Canada Coagulation Market, by End User
  - 12.1.7.4 Mexico
    - 12.1.7.4.1 Overview
    - 12.1.7.4.2 Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.1.7.4.3 Mexico Coagulation Market, by Disease Indication
    - 12.1.7.4.4 Mexico Coagulation Market, by Type
    - 12.1.7.4.4.1 Mexico Coagulation Market, by Clinical Laboratory Analyzers
    - 12.1.7.4.5 Mexico Coagulation Market, by Offering
    - 12.1.7.4.5.1 Mexico Coagulation Market, by Diagnosis
    - 12.1.7.4.5.2 US Coagulation Market, by Treatment
    - 12.1.7.4.6 Mexico Coagulation Market, by Technology
    - 12.1.7.4.7 Mexico Coagulation Market, by End User
12.2 Europe Coagulation Market, Revenue And Forecast to 2030
- 12.2.1 Overview
- 12.2.2 Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.2.3 Europe Coagulation Market, by Disease Indication
- 12.2.4 Europe Coagulation Market, by Type
  - 12.2.4.1 Europe Coagulation Market, by Clinical Laboratory Analyzers
- 12.2.5 Europe Coagulation Market, by Offering
  - 12.2.5.1 Europe Coagulation Market, by Diagnosis
  - 12.2.5.2 Europe Coagulation Market, by Treatment
- 12.2.6 Europe Coagulation Market, by Technology
- 12.2.7 Europe Coagulation Market, by End User
- 12.2.8 Europe Coagulation Market by Country
  - 12.2.8.1 Germany
    - 12.2.8.1.1 Overview
    - 12.2.8.1.2 Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.1.3 Germany Coagulation Market, by Disease Indication
    - 12.2.8.1.4 Germany Coagulation Market, by Type
    - 12.2.8.1.4.1 Germany Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.1.5 Germany Coagulation Market, by Offering
    - 12.2.8.1.5.1 Germany Coagulation Market, by Diagnosis
    - 12.2.8.1.5.2 Germany Coagulation Market, by Treatment
    - 12.2.8.1.6 Germany Coagulation Market, by Technology
    - 12.2.8.1.7 Germany Coagulation Market, by End User
  - 12.2.8.2 UK
    - 12.2.8.2.1 Overview
    - 12.2.8.2.1.1 UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.2.2 UK Coagulation Market, by Disease Indication
    - 12.2.8.2.3 UK Coagulation Market, by Type
    - 12.2.8.2.3.1 UK Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.2.4 UK Coagulation Market, by Offering
    - 12.2.8.2.4.1 UK Coagulation Market, by Diagnosis
    - 12.2.8.2.4.2 UK Coagulation Market, by Treatment
    - 12.2.8.2.5 UK Coagulation Market, by Technology
    - 12.2.8.2.6 UK Coagulation Market, by End User
  - 12.2.8.3 France
    - 12.2.8.3.1 Overview
    - 12.2.8.3.1.1 France Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.3.2 France Coagulation Market, by Disease Indication
    - 12.2.8.3.3 France Coagulation Market, by Type
    - 12.2.8.3.3.1 France Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.3.4 France Coagulation Market, by Offering
    - 12.2.8.3.4.1 France Coagulation Market, by Diagnosis
    - 12.2.8.3.4.2 France Coagulation Market, by Treatment
    - 12.2.8.3.5 France Coagulation Market, by Technology
    - 12.2.8.3.6 France Coagulation Market, by End User
  - 12.2.8.4 Italy
    - 12.2.8.4.1 Overview
    - 12.2.8.4.1.1 Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.4.2 Italy Coagulation Market, by Disease Indication
    - 12.2.8.4.3 Italy Coagulation Market, by Type
    - 12.2.8.4.3.1 Italy Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.4.4 Italy Coagulation Market, by Offering
    - 12.2.8.4.4.1 Italy Coagulation Market, by Diagnosis
    - 12.2.8.4.4.2 Italy Coagulation Market, by Treatment
    - 12.2.8.4.5 Italy Coagulation Market, by Technology
    - 12.2.8.4.6 Italy Coagulation Market, by End User
  - 12.2.8.5 Spain
    - 12.2.8.5.1 Overview
    - 12.2.8.5.2 Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.5.3 Spain Coagulation Market, by Disease Indication
    - 12.2.8.5.4 Spain Coagulation Market, by Type
    - 12.2.8.5.4.1 Spain Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.5.5 Spain Coagulation Market, by Offering
    - 12.2.8.5.5.1 Spain Coagulation Market, by Diagnosis
    - 12.2.8.5.5.2 Spain Coagulation Market, by Treatment
    - 12.2.8.5.6 Spain Coagulation Market, by Technology
    - 12.2.8.5.7 Spain Coagulation Market, by End User
  - 12.2.8.6 Rest of Europe
    - 12.2.8.6.1 Overview
    - 12.2.8.6.2 Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.6.3 Rest of Europe Coagulation Market, by Disease Indication
    - 12.2.8.6.4 Rest of Europe Coagulation Market, by Type
    - 12.2.8.6.4.1 Rest of Europe Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.6.5 Rest of Europe Coagulation Market, by Offering
    - 12.2.8.6.5.1 Rest of Europe Coagulation Market, by Diagnosis
    - 12.2.8.6.5.2 Rest of Europe Coagulation Market, by Treatment
    - 12.2.8.6.6 Rest of Europe Coagulation Market, by Technology
    - 12.2.8.6.7 Rest of Europe Coagulation Market, by End User
12.3 Asia Pacific Coagulation Market, Revenue and Forecast to 2030
- 12.3.1 Overview
- 12.3.2 Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.3.3 Asia Pacific Coagulation Market, by Disease Indication
- 12.3.4 Asia Pacific Coagulation Market, by Type
  - 12.3.4.1 Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
- 12.3.5 Asia Pacific Coagulation Market, by Offering
  - 12.3.5.1 Asia Pacific Coagulation Market, by Diagnosis
  - 12.3.5.2 Asia Pacific Coagulation Market, by Treatment
- 12.3.6 Asia Pacific Coagulation Market, by Technology
- 12.3.7 Asia Pacific Coagulation Market, by End User
- 12.3.8 Asia Pacific Coagulation Market by Country
  - 12.3.8.1 China
    - 12.3.8.1.1 Overview
    - 12.3.8.1.2 China Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.1.3 China Coagulation Market, by Disease Indication
    - 12.3.8.1.4 China Coagulation Market, by Type
    - 12.3.8.1.4.1 China Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.1.5 China Coagulation Market, by Offering
    - 12.3.8.1.5.1 China Coagulation Market, by Diagnosis
    - 12.3.8.1.5.2 China Coagulation Market, by Treatment
    - 12.3.8.1.6 China Coagulation Market, by Technology
    - 12.3.8.1.7 China Coagulation Market, by End User
  - 12.3.8.2 Japan
    - 12.3.8.2.1 Overview
    - 12.3.8.2.2 Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.2.3 Japan Coagulation Market, by Disease Indication
    - 12.3.8.2.4 Japan Coagulation Market, by Type
    - 12.3.8.2.4.1 Japan Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.2.5 Japan Coagulation Market, by Offering
    - 12.3.8.2.5.1 Japan Coagulation Market, by Diagnosis
    - 12.3.8.2.5.2 Japan Coagulation Market, by Treatment
    - 12.3.8.2.6 Japan Coagulation Market, by Technology
    - 12.3.8.2.7 Japan Coagulation Market, by End User
  - 12.3.8.3 India
    - 12.3.8.3.1 Overview
    - 12.3.8.3.2 India Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.3.3 India Coagulation Market, by Disease Indication
    - 12.3.8.3.4 India Coagulation Market, by Type
    - 12.3.8.3.4.1 India Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.3.5 India Coagulation Market, by Offering
    - 12.3.8.3.5.1 India Coagulation Market, by Diagnosis
    - 12.3.8.3.5.2 India Coagulation Market, by Treatment
    - 12.3.8.3.6 India Coagulation Market, by Technology
    - 12.3.8.3.7 India Coagulation Market, by End User
  - 12.3.8.4 Australia
    - 12.3.8.4.1 Overview
    - 12.3.8.4.2 Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.4.3 Australia Coagulation Market, by Disease Indication
    - 12.3.8.4.4 Australia Coagulation Market, by Type
    - 12.3.8.4.4.1 Australia Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.4.5 Australia Coagulation Market, by Offering
    - 12.3.8.4.5.1 Australia Coagulation Market, by Diagnosis
    - 12.3.8.4.5.2 Australia Coagulation Market, by Treatment
    - 12.3.8.4.6 Australia Coagulation Market, by Technology
    - 12.3.8.4.7 Australia Coagulation Market, by End User
  - 12.3.8.5 South Korea
    - 12.3.8.5.1 Overview
    - 12.3.8.5.2 South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.5.3 South Korea Coagulation Market, by Disease Indication
    - 12.3.8.5.4 South Korea Coagulation Market, by Type
    - 12.3.8.5.4.1 South Korea Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.5.5 South Korea Coagulation Market, by Offering
    - 12.3.8.5.5.1 South Korea Coagulation Market, by Diagnosis
    - 12.3.8.5.5.2 South Korea Coagulation Market, by Treatment
    - 12.3.8.5.6 South Korea Coagulation Market, by Technology
    - 12.3.8.5.7 South Korea Coagulation Market, by End User
  - 12.3.8.6 Rest of Asia Pacific
    - 12.3.8.6.1 Overview
    - 12.3.8.6.2 Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.6.3 Rest of Asia Pacific Coagulation Market, by Disease Indication
    - 12.3.8.6.4 Rest of Asia Pacific Coagulation Market, by Type
    - 12.3.8.6.4.1 Rest of Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.6.5 Rest of Asia Pacific Coagulation Market, by Offering
    - 12.3.8.6.5.1 Rest of Asia Pacific Coagulation Market, by Diagnosis
    - 12.3.8.6.5.2 Rest of Asia Pacific Coagulation Market, by Treatment
    - 12.3.8.6.6 Rest of Asia Pacific Coagulation Market, by Technology
    - 12.3.8.6.7 Rest of Asia Pacific Coagulation Market, by End User
12.4 Middle East & Africa Coagulation Market, Revenue and Forecast to 2030
- 12.4.1 Overview
- 12.4.2 Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.4.3 Middle East & Africa Coagulation Market, by Disease Indication
- 12.4.4 Middle East & Africa Coagulation Market, by Type
  - 12.4.4.1 Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
- 12.4.5 Middle East & Africa Coagulation Market, by Offering
  - 12.4.5.1 Middle East & Africa Coagulation Market, by Diagnosis
  - 12.4.5.2 Middle East & Africa Coagulation Market, by Treatment
- 12.4.6 Middle East & Africa Coagulation Market, by Technology
- 12.4.7 Middle East & Africa Coagulation Market, by End User
  - 12.4.7.1 Middle East & Africa Coagulation Market by Country
  - 12.4.7.2 Saudi Arabia
    - 12.4.7.2.1 Overview
    - 12.4.7.2.2 Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.4.7.2.3 Saudi Arabia Coagulation Market, by Disease Indication
    - 12.4.7.2.4 Saudi Arabia Coagulation Market, by Type
    - 12.4.7.2.4.1 Saudi Arabia Coagulation Market, by Clinical Laboratory Analyzer
    - 12.4.7.2.5 Saudi Arabia Coagulation Market, by Offering
    - 12.4.7.2.5.1 Saudi Arabia Coagulation Market, by Diagnosis
    - 12.4.7.2.5.2 Saudi Arabia Coagulation Market, by Treatment
    - 12.4.7.2.6 Saudi Arabia Coagulation Market, by Technology
    - 12.4.7.2.7 Saudi Arabia Coagulation Market, by End User
  - 12.4.7.3 South Africa
    - 12.4.7.3.1 Overview
    - 12.4.7.3.2 South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.4.7.3.3 South Africa Coagulation Market, by Disease Indication
    - 12.4.7.3.4 South Africa Coagulation Market, by Type
    - 12.4.7.3.4.1 South Africa Coagulation Market, by Clinical Laboratory Analyzer
    - 12.4.7.3.5 South Africa Coagulation Market, by Offering
    - 12.4.7.3.5.1 South Africa Coagulation Market, by Diagnosis
    - 12.4.7.3.5.2 South Africa Coagulation Market, by Treatment
    - 12.4.7.3.6 South Africa Coagulation Market, by Technology
    - 12.4.7.3.7 South Africa Coagulation Market, by End User
  - 12.4.7.4 UAE
    - 12.4.7.4.1 Overview
    - 12.4.7.4.2 UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.4.7.4.3 UAE Coagulation Market, by Disease Indication
    - 12.4.7.4.4 UAE Coagulation Market, by Type
    - 12.4.7.4.4.1 UAE Coagulation Market, by Clinical Laboratory Analyzer
    - 12.4.7.4.5 UAE Coagulation Market, by Offering
    - 12.4.7.4.5.1 UAE Coagulation Market, by Diagnosis
    - 12.4.7.4.5.2 UAE Coagulation Market, by Treatment
    - 12.4.7.4.6 UAE Coagulation Market, by Technology
    - 12.4.7.4.7 UAE Coagulation Market, by End User
  - 12.4.7.5 Rest of Middle East & Africa
    - 12.4.7.5.1 Overview
    - 12.4.7.5.2 Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.4.7.5.3 Rest of Middle East & Africa Coagulation Market, by Disease Indication
    - 12.4.7.5.4 Rest of Middle East & Africa Coagulation Market, by Type
    - 12.4.7.5.4.1 Rest of Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
    - 12.4.7.5.5 Rest of Middle East & Africa Coagulation Market, by Offering
    - 12.4.7.5.5.1 Rest of Middle East & Africa Coagulation Market, by Diagnosis
    - 12.4.7.5.5.2 Rest of Middle East & Africa Coagulation Market, by Treatment
    - 12.4.7.5.6 Rest of Middle East & Africa Coagulation Market, by Technology
    - 12.4.7.5.7 Rest of Middle East & Africa Coagulation Market, by End User
12.5 South & Central America Coagulation Market, Revenue and Forecast to 2030
- 12.5.1 Overview
- 12.5.2 South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.5.3 South & Central America Coagulation Market, by Disease Indication
- 12.5.4 South & Central America Coagulation Market, by Type
  - 12.5.4.1 South & Central America Coagulation Market, by Clinical Laboratory Analyzer
- 12.5.5 South & Central America Coagulation Market, by Offering
  - 12.5.5.1 South & Central America Coagulation Market, by Diagnosis
  - 12.5.5.2 South & Central America Coagulation Market, by Treatment
- 12.5.6 South & Central America Coagulation Market, by Technology
- 12.5.7 South & Central America Coagulation Market, by End User
- 12.5.8 South & Central America Coagulation Market by Country
  - 12.5.8.1 Brazil
    - 12.5.8.1.1 Overview
    - 12.5.8.1.2 Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.5.8.1.3 Brazil Coagulation Market, by Disease Indication
    - 12.5.8.1.4 Brazil Coagulation Market, by Type
    - 12.5.8.1.4.1 Brazil Coagulation Market, by Clinical Laboratory Analyzer
    - 12.5.8.1.5 Brazil Coagulation Market, by Offering
    - 12.5.8.1.5.1 Brazil Coagulation Market, by Diagnosis
    - 12.5.8.1.5.2 Brazil Coagulation Market, by Treatment
    - 12.5.8.1.6 Brazil Coagulation Market, by Technology
    - 12.5.8.1.7 Brazil Coagulation Market, by End User
  - 12.5.8.2 Argentina
    - 12.5.8.2.1 Overview
    - 12.5.8.2.2 Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.5.8.2.3 Argentina Coagulation Market, by Disease Indication
    - 12.5.8.2.4 Argentina Coagulation Market, by Type
    - 12.5.8.2.4.1 Argentina Coagulation Market, by Clinical Laboratory Analyzer
    - 12.5.8.2.5 Argentina Coagulation Market, by Offering
    - 12.5.8.2.5.1 Argentina Coagulation Market, by Diagnosis
    - 12.5.8.2.5.2 Argentina Coagulation Market, by Treatment
    - 12.5.8.2.6 Argentina Coagulation Market, by Technology
    - 12.5.8.2.7 Argentina Coagulation Market, by End User
  - 12.5.8.3 Rest of South & Central America
    - 12.5.8.3.1 Overview
    - 12.5.8.3.2 Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.5.8.3.3 Rest of South & Central America Coagulation Market, by Disease Indication
    - 12.5.8.3.4 Rest of South & Central America Coagulation Market, by Type
    - 12.5.8.3.4.1 Rest of South & Central America Coagulation Market, by Clinical Laboratory Analyzer
    - 12.5.8.3.5 Rest of South & Central America Coagulation Market, by Offering
    - 12.5.8.3.5.1 Rest of South & Central America Coagulation Market, by Diagnosis
    - 12.5.8.3.5.2 Rest of South & Central America Coagulation Market, by Treatment
    - 12.5.8.3.6 Rest of South & Central America Coagulation Market, by Technology
    - 12.5.8.3.7 Rest of South & Central America Coagulation Market, by End User

13. Coagulation Market-Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Coagulation Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Siemens Healthineers AG
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Diagnostica Stago, Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 ImproGen Diagnostik Kimya San. & Tic. Ltd.?ti.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Nordic Biomarker AB
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Sysmex Corp
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Helena Laboratories Corporation
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 F. Hoffmann-La Roche Ltd
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Genrui Biotech Co., Ltd.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Transasia Bio-Medicals Ltd
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Horiba Ltd.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About Us
15.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Coagulation Market Segmentation
Table 2. Global Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 3. Global Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 4. Global Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 5. Optical Technologies and Their Applications
Table 6. Mechanical Technologies and Their Applications
Table 7. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 8. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 9. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 10. North America Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 11. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 12. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 13. North America Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 14. North America Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 15. US Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 16. US Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 17. US Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 18. US Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 19. US Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 20. US Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 21. US Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 22. US Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 23. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 24. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 25. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 26. Canada Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 27. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 28. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 29. Canada Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 30. Canada Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 31. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 32. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 33. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 34. Mexico Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 35. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 36. US Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 37. Mexico Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 38. Mexico Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 39. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 40. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 41. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 42. Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 43. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 44. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 45. Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 46. Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 47. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 48. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 49. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 50. Germany Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 51. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 52. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 53. Germany Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 54. Germany Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 55. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 56. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 57. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 58. UK Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 59. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 60. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 61. UK Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 62. UK Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 63. France Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 64. France Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 65. France Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 66. France Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 67. France Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 68. France Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 69. France Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 70. France Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 71. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 72. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 73. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 74. Italy Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 75. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 76. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 77. Italy Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 78. Italy Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 79. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 80. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 81. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 82. Spain Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 83. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 84. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 85. Spain Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 86. Spain Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 87. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 88. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 89. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 90. Rest of Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 91. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 92. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 93. Rest of Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 94. Rest of Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 95. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 96. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 97. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 98. Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 99. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 100. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 101. Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 102. Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 103. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 104. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 105. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 106. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 107. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 108. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 109. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 110. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 111. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 112. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 113. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 114. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 115. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 116. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 117. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 118. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 119. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 120. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 121. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 122. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 123. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 124. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 125. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 126. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 127. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 128. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 129. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 130. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 131. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 132. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 133. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 134. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 135. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 136. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 137. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 138. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 139. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 140. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 141. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 142. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 143. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 144. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 145. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 146. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 147. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 148. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 149. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 150. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 151. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 152. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 153. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 154. Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 155. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 156. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 157. Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 158. Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 159. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 160. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 161. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 162. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 163. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 164. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 165. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 166. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 167. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 168. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 169. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 170. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 171. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 172. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 173. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 174. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 175. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 176. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 177. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 178. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 179. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 180. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 181. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 182. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 183. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 184. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 185. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 186. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 187. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 188. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 189. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 190. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 191. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 192. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 193. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 194. South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 195. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 196. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 197. South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 198. South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 199. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 200. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 201. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 202. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 203. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 204. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 205. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 206. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 207. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 208. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 209. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 210. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 211. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 212. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 213. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 214. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 215. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 216. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 217. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 218. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 219. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 220. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 221. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 222. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 223. Recent Inorganic Growth Strategies in the Coagulation Market
Table 224. Recent Organic Growth Strategies in the Coagulation Market
Table 225. Glossary of Terms, Coagulation Market

List Of Figures

Figure 1. Coagulation Market Segmentation, By Geography
Figure 2. North America - PEST Analysis
Figure 3. Coagulation Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Coagulation Market Revenue (US$ million), 2020 - 2030
Figure 6. Geography Analysis Market Revenue (US$ million), 2022 - 2030
Figure 7. Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 8. Vitamin K Deficiency: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Liver Disease: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Disseminated Intravascular Coagulation and Pulmonary Embolism: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Development of Circulating Anticoagulant: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Hemophilia: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Von Willebrand's Disease: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
Figure 16. Clinical Laboratory Analyzers: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Point-of-Care Testing Analyzers: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
Figure 19. Diagnosis: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Treatment: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 22. Optical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Mechanical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Electrochemical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 27. Clinical Laboratories: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Hospitals: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Coagulation Market, 2022 ($million)
Figure 31. North America Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 32. North America Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 33. US Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 34. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 35. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 36. Europe Coagulation Market, By Geography, 2022 ($million)
Figure 37. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 38. Europe Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 39. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 40. UK Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 41. France Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 42. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 43. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 44. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 45. Coagulation Market, By Geography, 2022 (US$ Million)
Figure 46. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 47. Asia Pacific Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 48. China Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 49. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 50. India Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 51. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 52. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 53. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 54. Coagulation Market, By Geography, 2022 And 2030 ($million)
Figure 55. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 56. Middle East & Africa Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 57. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 58. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 59. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 60. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 61. Coagulation Market, By Geography, 2022 ($million)
Figure 62. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 63. South & Central America Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 64. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 65. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 66. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 67. Growth Strategies in the Coagulation Market